Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.535
+0.060 (4.07%)
Apr 29, 2026, 9:35 AM EDT - Market open
Chemomab Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 11 | 10 | 34 | 6 | 37 | 79 | |
| Market Cap Growth | -45.05% | -70.24% | 466.14% | -83.65% | -53.12% | - | |
| Enterprise Value | 0 | 0 | 15 | -15 | -9 | 15 | |
| Last Close Price | 1.48 | 1.65 | 7.24 | 2.04 | 12.80 | 27.60 | |
| PB Ratio | 0.86 | 0.82 | 2.52 | 0.36 | 1.02 | 1.28 | |
| P/TBV Ratio | 0.86 | 0.82 | 2.52 | 0.36 | 1.02 | 1.28 | |
| Debt / Equity Ratio | - | - | 0.02 | 0.02 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.84 | -0.84 | -1.03 | -1.14 | -1.09 | -0.99 | |
| Net Debt / EBITDA Ratio | 1.09 | 1.09 | 0.95 | 0.76 | 1.39 | 4.93 | |
| Net Debt / FCF Ratio | 0.93 | 0.93 | 0.91 | 0.82 | 1.94 | 4.82 | |
| Quick Ratio | 7.15 | 7.15 | 4.51 | 4.15 | 5.98 | 23.15 | |
| Current Ratio | 9.08 | 9.08 | 4.98 | 4.32 | 6.18 | 23.66 | |
| Return on Equity (ROE) | -69.54% | -69.54% | -91.34% | -91.02% | -56.60% | -34.53% | |
| Return on Assets (ROA) | -38.86% | -38.86% | -47.10% | -48.80% | -33.20% | -20.12% | |
| Return on Capital Employed (ROCE) | -77.60% | -77.60% | -107.20% | -147.10% | -78.60% | -20.00% | |
| Earnings Yield | -84.69% | -88.57% | -40.86% | -401.76% | -74.96% | -15.86% | |
| FCF Yield | -104.82% | -109.62% | -45.08% | -391.69% | -55.42% | -16.03% | |
| Buyback Yield / Dilution | -42.10% | -42.10% | -52.79% | -3.26% | -9.70% | -51.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.